ATE267187T1 - Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen - Google Patents
Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungenInfo
- Publication number
- ATE267187T1 ATE267187T1 AT97904019T AT97904019T ATE267187T1 AT E267187 T1 ATE267187 T1 AT E267187T1 AT 97904019 T AT97904019 T AT 97904019T AT 97904019 T AT97904019 T AT 97904019T AT E267187 T1 ATE267187 T1 AT E267187T1
- Authority
- AT
- Austria
- Prior art keywords
- dihydrobenzofuranes
- inflammatory agents
- compounds useful
- related compounds
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/595,337 US5618835A (en) | 1996-02-01 | 1996-02-01 | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| PCT/US1997/001314 WO1997028147A1 (en) | 1996-02-01 | 1997-01-30 | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE267187T1 true ATE267187T1 (de) | 2004-06-15 |
Family
ID=24382842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97904019T ATE267187T1 (de) | 1996-02-01 | 1997-01-30 | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5618835A (de) |
| EP (1) | EP0888323B1 (de) |
| JP (1) | JP3095424B2 (de) |
| KR (1) | KR100322402B1 (de) |
| CN (1) | CN1125062C (de) |
| AT (1) | ATE267187T1 (de) |
| AU (1) | AU730262B2 (de) |
| BR (1) | BR9707247A (de) |
| CA (1) | CA2244203A1 (de) |
| DE (1) | DE69729183T2 (de) |
| DK (1) | DK0888323T3 (de) |
| ES (1) | ES2221950T3 (de) |
| MX (1) | MX9806250A (de) |
| NO (1) | NO983530L (de) |
| WO (1) | WO1997028147A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001514663A (ja) * | 1997-03-12 | 2001-09-11 | エスモンド，ロバート ダブリュー． | アルツハイマー病を処置または予防するための方法 |
| AU7933298A (en) * | 1997-06-27 | 1999-01-19 | Kaneka Corporation | Heat shock factor activity inhibitors |
| KR20010031319A (ko) | 1997-10-24 | 2001-04-16 | 요시히코 시오노 | 항류마티스제 |
| US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
| US6191154B1 (en) | 1998-11-27 | 2001-02-20 | Case Western Reserve University | Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
| EP1406895B1 (de) | 2001-06-13 | 2008-08-27 | Magnachem International Laboratories, Inc. | Lactonformulierungen und verfahren zur anwendung |
| EP2147679B1 (de) | 2001-07-25 | 2014-06-25 | Raptor Pharmaceutical, Inc. | Zusammensetzungen für den Blut-Hirn-Schrankentransport |
| WO2004041217A2 (en) | 2002-11-05 | 2004-05-21 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations and method of use |
| EP1567112B1 (de) * | 2002-11-22 | 2008-10-15 | Smithkline Beecham Corporation | THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN |
| WO2005102315A1 (en) | 2004-04-23 | 2005-11-03 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations for pain control |
| EP2392258B1 (de) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-Informatiksystem |
| PE20070083A1 (es) * | 2005-06-08 | 2007-01-27 | Smithkline Beecham Corp | (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona |
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗 |
| US20100286041A1 (en) * | 2007-03-22 | 2010-11-11 | Smithkline Beecham Corporation | (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| AU2009308423B2 (en) | 2008-10-24 | 2013-08-29 | Magnachem International Laboratories, Inc. | Method for screening for compounds selectively interacting with Rad9 |
| DE112010000714B4 (de) | 2009-01-27 | 2014-06-26 | National University Corporation Nagoya University | Membranspannungsmessvorrichtung |
| PL3395372T3 (pl) | 2009-02-20 | 2022-07-25 | EnhanX Biopharm Inc. | Układ do dostarczania leków na bazie glutationu |
| CN102458374A (zh) | 2009-05-06 | 2012-05-16 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6019305B2 (ja) * | 1976-07-02 | 1985-05-15 | ウェルファイド株式会社 | ジヒドロベンゾフラン誘導体 |
| IT1093805B (it) * | 1978-01-31 | 1985-07-26 | Erba Carlo Spa | Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione |
| US4470440A (en) * | 1982-09-30 | 1984-09-11 | Thor Harry A | Impact producing tool |
| EP0273647B1 (de) * | 1986-12-27 | 1992-03-11 | Takeda Chemical Industries, Ltd. | 2,3-Dihydro-Cumaron-Derivate, ihre Herstellung und Verwendung |
| US4849428A (en) * | 1987-11-23 | 1989-07-18 | The Procter & Gamble Company | Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use |
| JP2855341B2 (ja) * | 1988-06-10 | 1999-02-10 | 武田薬品工業株式会社 | 新規２―置換クマラン誘導体 |
| US4966907A (en) * | 1988-08-12 | 1990-10-30 | Merck & Co., Inc. | 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis |
| FR2645537B1 (fr) * | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
| US4975457A (en) * | 1989-09-25 | 1990-12-04 | Merck & Co., Inc. | Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis |
| EP0458970A4 (en) * | 1989-11-17 | 1992-05-13 | Meiji Milk Products Company Limited | Benzofuran derivative, process for preparing the same, and pharmaceutical comprising the same as active ingredient |
| US5091533A (en) * | 1990-03-12 | 1992-02-25 | Merck Frosst Canada, Inc. | 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| NZ237566A (en) * | 1990-03-27 | 1994-03-25 | Smithkline Beecham Corp | Substituted amide and hydroxyamine derivatives and pharmaceutical compositions |
| CN1191243C (zh) * | 1994-07-27 | 2005-03-02 | 范德比尔特大学 | 用作抗炎剂的二氢苯并呋喃和相关化合物 |
| US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
-
1996
- 1996-02-01 US US08/595,337 patent/US5618835A/en not_active Expired - Fee Related
-
1997
- 1997-01-30 DE DE69729183T patent/DE69729183T2/de not_active Expired - Fee Related
- 1997-01-30 AT AT97904019T patent/ATE267187T1/de not_active IP Right Cessation
- 1997-01-30 DK DK97904019T patent/DK0888323T3/da active
- 1997-01-30 CA CA002244203A patent/CA2244203A1/en not_active Abandoned
- 1997-01-30 AU AU18433/97A patent/AU730262B2/en not_active Ceased
- 1997-01-30 ES ES97904019T patent/ES2221950T3/es not_active Expired - Lifetime
- 1997-01-30 CN CN97192018A patent/CN1125062C/zh not_active Expired - Fee Related
- 1997-01-30 KR KR1019980705950A patent/KR100322402B1/ko not_active Expired - Fee Related
- 1997-01-30 WO PCT/US1997/001314 patent/WO1997028147A1/en not_active Ceased
- 1997-01-30 JP JP09527762A patent/JP3095424B2/ja not_active Expired - Fee Related
- 1997-01-30 EP EP97904019A patent/EP0888323B1/de not_active Expired - Lifetime
- 1997-01-30 BR BR9707247A patent/BR9707247A/pt not_active Application Discontinuation
-
1998
- 1998-07-31 NO NO983530A patent/NO983530L/no not_active Application Discontinuation
- 1998-08-03 MX MX9806250A patent/MX9806250A/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO983530D0 (no) | 1998-07-31 |
| DK0888323T3 (da) | 2004-08-09 |
| JPH11506121A (ja) | 1999-06-02 |
| WO1997028147A1 (en) | 1997-08-07 |
| US5618835A (en) | 1997-04-08 |
| CN1125062C (zh) | 2003-10-22 |
| NO983530L (no) | 1998-09-30 |
| AU1843397A (en) | 1997-08-22 |
| DE69729183D1 (de) | 2004-06-24 |
| CA2244203A1 (en) | 1997-08-07 |
| CN1210530A (zh) | 1999-03-10 |
| JP3095424B2 (ja) | 2000-10-03 |
| AU730262B2 (en) | 2001-03-01 |
| KR19990082222A (ko) | 1999-11-25 |
| EP0888323B1 (de) | 2004-05-19 |
| MX9806250A (es) | 1998-11-30 |
| DE69729183T2 (de) | 2004-10-07 |
| KR100322402B1 (ko) | 2002-05-09 |
| ES2221950T3 (es) | 2005-01-16 |
| EP0888323A1 (de) | 1999-01-07 |
| BR9707247A (pt) | 1999-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE267187T1 (de) | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| PT902789E (pt) | Derivados de androsteno | |
| SE9504661D0 (sv) | New compounds | |
| EE04799B1 (et) | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| ATE230749T1 (de) | Glucocorticoid selektive entzündungshemmende mittel | |
| RU95106674A (ru) | Полиеновые соединения, фармацевтическая и косметическая композиция на их основе | |
| IT1285770B1 (it) | Composti corticoidei | |
| NO954878L (no) | Pyrrolderivater | |
| BR9711986A (pt) | Compostos farmac-uticos | |
| SE9801494D0 (sv) | Novel use | |
| DK0714387T3 (da) | Hidtil ukendte bis-naphthalimider til behandling af cancer | |
| DE69613395D1 (de) | Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel | |
| ATE187956T1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
| DE60005517D1 (de) | Kaliumkanal-blockierende mittel | |
| SE9504662D0 (sv) | New compounds | |
| DE69535697D1 (de) | Dihydrobenzofurane und verwandte verbindungen als entzündungshemmende mittel | |
| ATE189395T1 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen | |
| NZ505085A (en) | Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi | |
| ID21653A (id) | Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif | |
| MX9800697A (es) | Uso de glicosidos de calendula para el tratamiento de psoriasis. | |
| IT1255678B (it) | Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale. | |
| ITRM920516A1 (it) | Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |